News & Articles
Selected Filters:
Abbott introduces next-generation 3D cardiac mapping platform in Europe and Australia
The EnSite X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures
Researchers to develop anti-COVID-19 coating for PPE
This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings
Olympus announces acquisition of FH ORTHO, an international orthopedics company in France
To expand Minimally Invasive Surgery field by reinforcing its orthopedics business
Nominate your favorite new lab product for a Scientists’ Choice Award: Nominations open today
Which new products made the most difference to your lab work this year?
PerkinElmer introduces no-wash immunoassay to help drive neuroscience disease research forward
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
SelectScience: Why mental health is top of our agenda
FDA approves Gilead's antiviral remdesivir drug for treatment of COVID-19
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
MIS-C detection: Beckman Coulter partners with BARDA in rapid diagnostic for pediatric complication of SARS-CoV-2
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
Siemens Healthineers launches rapid antigen test for the detection of SARS-CoV-2
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
Syndromic testing: A powerful approach for simultaneous pathogen detection
Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing
World-class speaker lineup announced for Virtual Neuroscience Summit 2020
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field
Study shows early treatment for leg ulcers leads to better outcomes for patients
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
Abbott receives CE mark for MitraClip heart valve repair device to treat mitral regurgitation
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
DiaSorin's Simplexa COVID-19 direct molecular test CE marked for saliva specimens
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
Roche granted FDA clearance for BK virus test to support better care for transplant patients
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
DiaSorin partners with MeMed to develop and commercialize diagnostics solution
Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections
Sherlock Biosciences announces clinical data from study of Sherlock CRISPR SARS-CoV-2 Kit
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
Teknova scales up production of viral transport media to support global response to COVID-19
Rapid increase in production of VTM and saline will help boost virus testing
Fujitsu and Tokyo Shinagawa Hospital to develop an AI-based technology to support COVID-19 diagnosis
The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses
Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions